Fundraising Fox
/Companies
Sign in

Revilico

1 known investors

Find your way into Revilico

197 people in our graph can introduce you to the Revilico team.

Sign up to see every warm intro you have to Revilico

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Revilico team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Revilico builds an operating system for pharmaceutical R&D that unifies computational drug discovery tools—including molecular dynamics, quantum chemistry, generative chemistry, and virtual cell simulations—with integrated wet-lab validation. The platform serves pharmaceutical researchers and biotech companies developing small molecule drugs, covering all phases from target identification through lead optimization and preclinical development.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

CKChristopher Korban
Christopher KorbanFounderChristopher Korban is Co-Founder and CEO of Revilico, which develops computational and AI-driven tools for pharmaceutical drug discovery. He studied at UCLA, where he conducted research in high-throughput screening, molecular simulation, biomarker sensing, and drug delivery systems under faculty including Robert Damoiseaux.
CCChristian Chung
Christian ChungFounder

Investors · 1

Related companies · 4

Revalia Bio, Inc.Revalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development. It operates an Organ ICU facility and works with organ procurement organizations and healthcare institutions to serve pharma, biotech, and medical device companies.
PelicoPelico provides an AI-native operations platform for complex manufacturers to eliminate execution blind spots and keep teams aligned in real time. The platform helps manufacturers in aerospace, defense, industrial equipment, luxury, and transportation systems anticipate disruptions and coordinate decisions across production, planning, and supply chain functions.
RevvityRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
PimlicoPimlico provides a gas sponsorship engine for blockchain applications that enables developers to abstract away gas fees from users. The platform allows apps to sponsor transactions, accept stablecoin payments for gas, or enforce custom policy rules, letting users transact on 100+ chains without needing native tokens or understanding gas costs.

Companies working in the same space as Revilico.

In the news

MAX BioPharma and Revilico Announce Collaboration on Target Identification and Mechanistic Studies for Oxysterol Drug Candidatesfinance.yahoo.com · Aug 2025

Frequently asked questions

What does Revilico do?
Revilico builds an operating system for pharmaceutical R&D that unifies computational drug discovery tools—including molecular dynamics, quantum chemistry, generative chemistry, and virtual cell simulations—with integrated wet-lab validation. The platform serves pharmaceutical researchers and biotech companies developing small molecule drugs, covering all phases from target identification through lead optimization and preclinical development.
Who founded Revilico?
Revilico was founded by Christopher Korban, Christian Chung.
Who are Revilico's investors?
Revilico's investors include Mighty Capital.